Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS - Schedule of fair value of impaired notes receivable (Details)

v3.22.2
FAIR VALUE MEASUREMENTS - Schedule of fair value of impaired notes receivable (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Marketable securities $ 10,000 $ 39,793
Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Marketable securities $ 10,000 $ 39,793